Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

28,757 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Racial disparity in mortality from tuberculosis in the US between states with and without a history of Jim-Crow laws: an analysis of the Global Burden of Disease (GBD) and risk factors study, 1990 to 2019.
Gona PN, Estrada-Martinez LM, Zhang L, Gona CM, Mody A, Rao SR, Cooper J, Mack-Shelton K, Chen P, Leveille SG, Mokdad AH; G. B. D. 2019 T. B. Racial Disparity. Gona PN, et al. Among authors: chen p. BMC Public Health. 2024 Nov 7;24(1):3075. doi: 10.1186/s12889-024-20522-9. BMC Public Health. 2024. PMID: 39506669 Free PMC article.
Musculoskeletal Ultrasound Assessment of the Clinical Efficacy of the Combination of Acupressure and "Three Methods of Neck Movement (TCM)" Therapy in the Treatment of Cervical Spondylosis: A Study Protocol for a Randomized Controlled Trial.
Zuo J, Zeng X, Ma H, Chen P, Cai X, Fan Z, Qu J. Zuo J, et al. Among authors: chen p. J Pain Res. 2024 Nov 8;17:3651-3665. doi: 10.2147/JPR.S469511. eCollection 2024. J Pain Res. 2024. PMID: 39534754 Free PMC article.
Comparison of drug-eluting bead transarterial chemoembolization combined with apatinib versus drug-eluting bead transarterial chemoembolization for the treatment of unresectable hepatocellular carcinoma: a randomized, prospective, multicenter phase III trial.
Duan X, Li H, Kuang D, Chen P, Zhang M, Li T, Jiao D, Li Y, He X, Xing C, Wang H, Liu Y, Xie L, Zhang S, Zhang Q, Zhu P, Chang Y, Xie J, Ren J, Han X. Duan X, et al. Among authors: chen p. Signal Transduct Target Ther. 2024 Nov 13;9(1):304. doi: 10.1038/s41392-024-02012-x. Signal Transduct Target Ther. 2024. PMID: 39532849 Clinical Trial.
28,757 results
You have reached the last available page of results. Please see the User Guide for more information.